Product Summary
Anastrozole (CAS 120511-73-1, ZD1033/Arimidex) is a leading nonsteroidal aromatase inhibitor API for postmenopausal hormone-positive breast cancer therapy. Our pharma-grade raw powder ≥99% HPLC purity is available from gram sample to bulk kg packing for pharmaceutical formulation and preclinical ...
GMP factory supply Anastrozole Powder high purity CAS 120511-73-1 Anastrozole
Basic Properties
Trading Properties
GMP Anastrozole powder high purity
,Anastrozole API CAS 120511-73-1
,Pharmaceutical grade Anastrozole powder
| Item | Details |
|---|---|
| Product Name | Anastrozole |
| CAS No. | 120511-73-1 |
| Synonyms | Arimidex, ZD1033, ICI-D1033 |
| Chemical Name | 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropiononitrile) |
| Molecular Formula | C17H19N5 |
| Molecular Weight | 293.37 |
| MDL Number | MFCD00866298 |
| ATC Code | L02BG03 |
| Appearance | White to off-white crystalline powder |
| Purity | ≥99.0% HPLC(USP/EP Pharma Grade) |
| Melting Point | 81~82℃ |
| Density | 1.08±0.1 g/cm³ |
| Solubility | Freely soluble in acetonitrile,methanol,ethanol,DMSO(40mg/mL); Slightly soluble in water(0.53mg/mL,25℃) |
| Storage | Sealed dry & away from light;Short-term: 15~25℃;Long-term: 2~8℃/-20℃ sealed |
| Mechanism | Potent selective non-steroidal aromatase inhibitor, suppress aromatase activity to block peripheral synthesis, cut level for hormone-dependent tumor inhibition |
| Application | 1. Oral API for breast cancer tablet(1mg/tablet original Arimidex)
|
| Standard | USP, EP pharmacopoeia specification |

Please use our online inquiry contact form below if you have any questions, our team will get back to you as soon as possible.